Articles Tagged With:
-
A Fluid Bolus Peri-Intubation Does Not Prevent Cardiovascular Collapse
In this randomized pragmatic clinical trial, a peri-intubation intravenous fluid bolus administered to critically ill adults undergoing tracheal intubation with positive pressure ventilation did not significantly reduce the risk of cardiovascular collapse.
-
Outcomes of COVID-19-Associated Acute Myocarditis
In a review of COVID-19-associated acute myocarditis, investigators learned it is a rare complication that can occur without concomitant pneumonia, and frequently presents as cardiogenic shock. With supportive therapy, the short-term mortality rate is low.
-
Cirrhosis and Infections
Infections in patients with cirrhosis are frequent and potentially lethal, with pneumonia associated with the highest risk for mortality.
-
Postpartum Contraception Care at Catholic Hospitals
A survey using a probability sample of adult, reproductive-age women in the United States revealed that most women did not expect restrictions on care at Catholic hospitals, especially for services viewed with less stigma than abortion, and did not realize that Catholic hospitals are restricted in providing contraception and female sterilization.
-
Cervical Cancer Screening in Women Older than 65 Years of Age
Women diagnosed with cervical cancer after age 65 years are more likely to have locally advanced or metastatic disease, and survival decreases with increasing age and stage of diagnosis.
-
Prevention of Perineal Injury During the Second Stage of Labor
This randomized clinical trial in nulliparous women demonstrated that the hands-off technique reduced the risk for perineal injuries when compared to the hands-on technique during the second stage of labor.
-
What Is the Best Oral Emergency Contraceptive for Individuals with Obesity?
In this randomized controlled trial of 70 obese women, double dosing levonorgestrel emergency contraception (3 mg vs. 1.5 mg) did not prevent more follicle ruptures and, therefore, is unlikely to improve emergency contraception performance in this population.
-
Are SGLT2 Inhibitors Effective for HFpEF Patients Without Diabetes?
After comparing empagliflozin vs. placebo for patients with heart failure and preserved left ventricular ejection fraction, researchers found no differences in the significant reduction of the primary outcome of cardiovascular death or heart failure hospitalization over 36 months based on whether patients were diabetic.
-
Predicting the Tolerability of Sacubitril/Valsartan in Advanced Heart Failure
An analysis of the sacubitril/valsartan run-in period for chronic, advanced heart failure patients showed 18% could not tolerate the lowest dose, usually because of hypotension or renal dysfunction. Investigators identified six predictors of non-tolerance, which may help clinicians choose the best candidates.
-
Provocative Testing with Intracoronary Acetylcholine as Part of Cardiac Catheterization Evaluation
In this systematic review and meta-analysis of invasive coronary provocation testing, intracoronary acetylcholine was found to be a safe procedure, with low rates of major complications.